Hypothalamic resistin induces hepatic insulin resistance

J Clin Invest. 2007 Jun;117(6):1670-8. doi: 10.1172/JCI30440. Epub 2007 May 24.

Abstract

Circulating resistin stimulates endogenous glucose production (GP). Here, we report that bi-directional changes in hypothalamic resistin action have dramatic effects on GP and proinflammatory cytokine expression in the liver. The infusion of either resistin or an active cysteine mutant in the third cerebral ventricle (icv) or in the mediobasal hypothalamus stimulated GP independent of changes in circulating levels of glucoregulatory hormones. Conversely, central antagonism of resistin action markedly diminished the ability of circulating resistin to enhance GP. We also report that centrally mediated mechanisms partially control resistin-induced expression of TNF-alpha, IL-6, and SOCS-3 in the liver. These results unveil what we believe to be a novel site of action of resistin on GP and inflammation and suggest that hypothalamic resistin action can contribute to hyperglycemia in type 2 diabetes mellitus.

Publication types

  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Cytokines / genetics
  • Diabetes Mellitus, Type 2 / etiology
  • Diabetes Mellitus, Type 2 / genetics
  • Diabetes Mellitus, Type 2 / metabolism
  • Gluconeogenesis / drug effects
  • Humans
  • Hypothalamus / metabolism*
  • Inflammation Mediators / metabolism
  • Injections, Intraventricular
  • Insulin Resistance / physiology*
  • Liver / drug effects
  • Liver / metabolism*
  • Male
  • Mutagenesis, Site-Directed
  • Obesity / complications
  • Obesity / genetics
  • Obesity / metabolism
  • Rats
  • Rats, Sprague-Dawley
  • Recombinant Proteins / genetics
  • Recombinant Proteins / metabolism
  • Recombinant Proteins / pharmacology
  • Resistin / genetics
  • Resistin / metabolism*
  • Resistin / pharmacology

Substances

  • Cytokines
  • Inflammation Mediators
  • Recombinant Proteins
  • Resistin
  • Retn protein, rat